6160.HK
Price:
$185.5
Market Cap:
$34.31B
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Industry
Biotechnology
IPO Date
2018-08-08
Stock Exchange
HKSE
Ticker
6160.HK
According to BeOne Medicines AG’s latest financial reports and current stock price. The company's current ROE is 1.86%. This represents a change of 642.18% compared to the average of 0.25% of the last 4 quarters.
The mean historical ROE of BeOne Medicines AG over the last ten years is -28.22%. The current 1.86% ROE has changed -106.60% with respect to the historical average. Over the past ten years (40 quarters), 6160.HK's ROE was at its highest in in the December 2015 quarter at 26.78%. The ROE was at its lowest in in the December 2022 quarter at -72.30%.
Average
-28.22%
Median
-29.35%
Minimum
-97.16%
Maximum
56.11%
Discovering the peaks and valleys of BeOne Medicines AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.36%
Maximum Annual ROE = 56.11%
Minimum Annual Increase = -179.11%
Minimum Annual ROE = -97.16%
| Year | ROE | Change |
|---|---|---|
| 2024 | -19.35% | -22.37% |
| 2023 | -24.93% | -45.47% |
| 2022 | -45.71% | 95.77% |
| 2021 | -23.35% | -44.40% |
| 2020 | -42.00% | -56.78% |
| 2019 | -97.16% | 152.88% |
| 2018 | -38.42% | 182.36% |
| 2017 | -13.61% | -59.72% |
| 2016 | -33.78% | -160.20% |
| 2015 | 56.11% | -179.11% |
The current ROE of BeOne Medicines AG (6160.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-30.00%
5-year avg
-31.07%
10-year avg
-28.22%
BeOne Medicines AG’s ROE is less than WuXi AppTec Co., Ltd. (23.34%), less than Innovent Biologics, Inc. (8.22%), less than WuXi Biologics (Cayman) Inc. (9.67%), greater than Akeso, Inc. (-12.77%), less than Hansoh Pharmaceutical Group Company Limited (16.00%), less than Sino Biopharmaceutical Limited (11.85%), less than JD Health International Inc. (8.34%), less than TransThera Sciences (Nanjing) Inc. (0%), less than 3SBio Inc. (14.85%), greater than RemeGen Co., Ltd. (-44.94%),
| Company | ROE | Market cap |
|---|---|---|
| 23.34% | $288.51B | |
| 8.22% | $141.88B | |
| 9.67% | $134.43B | |
| -12.77% | $103.23B | |
| 16.00% | $226.54B | |
| 11.85% | $115.54B | |
| 8.34% | $189.69B | |
| 0% | $56.01B | |
| 14.85% | $64.36B | |
| -44.94% | $41.92B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BeOne Medicines AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BeOne Medicines AG's ROE?
How is the ROE calculated for BeOne Medicines AG (6160.HK)?
What is the highest ROE for BeOne Medicines AG (6160.HK)?
What is the 3-year average ROE for BeOne Medicines AG (6160.HK)?
What is the 5-year average ROE for BeOne Medicines AG (6160.HK)?
How does the current ROE for BeOne Medicines AG (6160.HK) compare to its historical average?